Navigation Links
Vasopressin Found To Boost Survival In Sudden Cardiac arrest

Each year, more than 600,000 people die of sudden cardiac arrest in North America and Europe, usually because of // a heart attack or a heart rhythm disturbance.
When medical personnel arrive, nearly 70 percent of victims have ventricular fibrillation, in which the heart's main pumping chambers flutter wildly and pump little blood. Less than 20 percent of these patients survive to go home.

About 30 percent of victims, usually patients who have been down longer, have asystole, and nearly all die.
For a century, cardiac arrest victims have been given epinephrine, a synthetic adrenaline that constricts blood vessels and boosts blood pressure. It is often administered when shocking the heart with a defibrillator fails to revive the patient.

Vasopressin, a synthetic hormone that narrows blood vessels, has been around for decades. A few years ago, the International Liaison Committee on Resuscitation revised its guidelines to add vasopressin as an alternative first drug. That was partly because epinephrine sometimes increases irregular rhythms and decreases oxygen supply to the brain after resuscitation.

Researchers studied 1,186 cardiac arrest patients treated in 33 communities in Austria, Germany and Switzerland from 1999 to 2002.
After ambulance crews tried defibrillation, half the patients not resuscitated then got one or more injections of vasopressin and the other half got epinephrine.Using vasopressin improved the chances of reaching a hospital alive by about 40 percent, and tripled the chances of going home from the hospital, in patients with the most deadly type of cardiac arrest, asystole, where all heart activity has stopped. Still, only 5 percent who got vasopressin made it home.

Researchers say their findings should soon change international guidelines for treating people in cardiac arrest outside a hospital .
However these advances should be translated into a new standard of care as soon as possi
'"/>




Page: 1 2

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...hadrak district now has hopes of pursuing his post...ervened //in his struggle to secure a study loan. ...ed the first position in his graduation in social ...he National Institute of Social Work and Social Sc...
...that by tailoring the intensity of radiation to in...intensive chemotherapy improves outcome for those/...tors led by St. Jude Children’s Research Hospital ...measures for childhood brain cancer medulloblastom...
...s are thought to be inhabited by a rather peculiar... which has peptides attached// together in a patte...nt in the DNA template. This revelation is far rem...e molecular biology textbooks. This discovery ha...
...etic pathway that could help in the eventually hel... The researchers from the Oregon Health & Science ... which demonstrates as to how a genes over-express...o change over from creating hair follicles to crea...
Other Medicine News:Health News:Survival rates improve with better treatment options for medulloblastoma 2Health News:Survival rates improve with better treatment options for medulloblastoma 3Health News:Discovery of A New Genetic Pathway Could Lead To Treatment Of Skin Problems And Cancer 2
(Date:9/3/2008)...results from chronically infected Hepatitis C,pati...ained earlier in 2008, - Study is the first to s... antiviral effect of therapeutic Hepatitis C vac...rt move into a second generation, vaccine formula...gh TLR activation, ...
(Date:9/3/2008)...t. 3 /- Panacea Pharmaceuticals,Inc....r 7,413,737 covering,antibodies against human aspa...rietary human cancer biomarker and therapeutic tar...ion with the Massachusetts Institute of,Technology... to this patent,for development of human cancer di...
(Date:9/3/2008)...ions, Updates Zingo Launch Progress and Adlea ... Conference Call Today at 11:30 am ET, SO...stCall/ -- Anesiva,Inc. (Nasdaq: ANSV ) announce...ns to focus on commercial and late-stage product d...alty pharmaceutical pain management,company. The c...
(Date:9/3/2008)... 3 /- A sub-analysis of,the...nt with prasugrel,compared with clopidogrel signif... attacks (7.4 percent vs. 9.7 percent, p<0.0001), ...he time of an artery-opening,procedure known as pe...,occurred spontaneously during the longer-term mai...
Breaking Medicine Technology:Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6SpectraScience Adds Industry Veteran to Executive Team 21878 1SpectraScience Adds Industry Veteran to Executive Team 21878 2Dont Let Gas Ruin Your Summer BBQ 21876 1Dont Let Gas Ruin Your Summer BBQ 21876 2Cell Therapeutics Inc Repays 2411 0 million Balance of 2008 Convertible Debt 5989 1Cell Therapeutics Inc Repays 2411 0 million Balance of 2008 Convertible Debt 5989 2Fitness a Key Element in Determining Male Diabetics Longevity 21874 1Fitness a Key Element in Determining Male Diabetics Longevity 21874 2
...4 inhibitor, possessing Ki of 27,pM, BOSTON, June ...Inc., a privately held drug discovery biopharmaceu...potent, smart DPP-4 inhibitor,ARI-2243, presented...ciation meeting in Chicago, Illinois. The results ...potent inhibitor of DPP-4 and,produced superior re...
... development of DG041 as an,effective anti-platele... Iceland, June 25, 2007 /PRNewswire-FirstCall/ --,...velopment of,DG041, the company,s Phase II develop...ombosis. The results of the Phase IIa and,clinical...revious,findings demonstrating DG041,s profile as ...
Other Medicine Technology:Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 2Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 3Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4,Inhibitor, ARI-2243, at the ADA 4Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 2Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 3Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 4Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 5Positive Clinical Results for DG041 Lead Product Development,Highlights at deCODE R&D Event 6
Surgitie&trade Single Use Ligating Loops without Delivery System with POLYSORB™.
ENDO STITCH&trade Triple-Stitch Single Use Loading Units for use with ENDO Stitch* 10 mm Suturing Device.
ENDO STITCH™ Single Use Loading Units.
...trade; ENDO STITCH™ device is designed for i...d Auto Suture™ trocar sleeves or larger size...he Auto Suture™ ENDO STITCH™ 10 mm sin...DO STITCH™ needle, loaded from a single use ...
Medicine Products: